Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype?

J Rheumatol. 2022 Jan;49(1):120. doi: 10.3899/jrheum.210724. Epub 2021 Oct 1.

Authors

Agathe Sauret¹, Julien Stievenart¹, Perrine Smets¹, Louis Olagne¹, Benedicte Guelon¹, Olivier Aumaître^{1

2}, Marc André^{1

2}, Ludovic Trefond^{3

2}

Affiliations

¹ CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied.
² Université Clermont Auvergne, Inserm U1071, INRA USC2018, M2iSH, Clermont-Ferrand, France.
³ CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied; [email protected].

PMID: 34599047
DOI: 10.3899/jrheum.210724

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Giant Cell Arteritis*
Humans
Phenotype
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines